flufenamic acid has been researched along with dinoprostone in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (41.18) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Gögelein, H; Siemer, C | 2 |
| Hamilton, JA; Leizer, T; Lingelbach, SR | 1 |
| Ishii, K; Kadokawa, T; Motoyoshi, S; Nakamura, H; Seto, Y; Shimoda, A | 1 |
| Eilon, G; Mundy, GR; Saez, S; Valentin-Opran, A | 1 |
| Gross, J; Shohami, E | 1 |
| Brown, M; Dziak, R; Farr, D; Pochal, W; Shapiro, E; Weinfeld, N | 1 |
| Feinstein, MB; Raisz, LG; Rodan, GA; Rodan, SB; Simmons, HA; Walenga, RW | 1 |
| Bass, P; Gullikson, GW; Sender, M | 1 |
| Föller, M; Huber, SM; Kasinathan, RS; Koka, S; Lang, F | 1 |
| Chen, Y; Kathpalia, PP; Pao, AC; Rajagopal, M; Thomas, SV | 1 |
| Caughie, C; Doi, A; Elsen, FP; Garcia, AJ; Koch, H; Ramirez, JM; Zanella, S | 1 |
| Chen, P; Fang, YJ; Gu, H; Liu, DD; Mei, YA | 1 |
| Duan, XC; Feng, ZH; Guo, Y; Li, H; Li, ZY; Liao, A; Liu, M; Wang, GX; Wang, JR; Wang, SM; Xu, MQ; Yin, YF; Zhang, S; Zhang, SQ; Zhang, X | 1 |
1 review(s) available for flufenamic acid and dinoprostone
| Article | Year |
|---|---|
Nonselective cation channels in cells of the crypt-base of rat distal colon.
Topics: Animals; Cations; Cell Membrane; Colforsin; Colon; Dinoprostone; Epithelial Cells; Epithelium; Flufenamic Acid; Humans; In Vitro Techniques; Ion Channels; Meglumine; Membrane Potentials; Muscle, Smooth; Rats; Sodium | 1993 |
16 other study(ies) available for flufenamic acid and dinoprostone
| Article | Year |
|---|---|
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Activation of nonselective cation channels in the basolateral membrane of rat distal colon crypt cells by prostaglandin E2.
Topics: Animals; Carbachol; Cell Membrane; Colon; Dinoprostone; Flufenamic Acid; In Vitro Techniques; Ion Channel Gating; Ion Channels; Male; Mefenamic Acid; Membrane Potentials; Nystatin; Rats; Rats, Inbred Strains | 1992 |
The stimulation of human synovial fibroblast plasminogen activator activity. Involvement of cyclic AMP and cyclooxygenase products.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Cells, Cultured; Cholera Toxin; Cyclic AMP; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; Enzyme Activation; Fibroblasts; Flufenamic Acid; Humans; Indomethacin; Plasminogen Activators; Prostaglandins; Prostaglandins E; Synovial Membrane; Tretinoin | 1986 |
[The mode of anti-inflammatory action of a topical non-steroidal anti-inflammatory drug, etofenamate].
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Erythrocyte Membrane; Flufenamic Acid; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Lipoxygenase Inhibitors; Macrophages; Male; Mast Cells; Peritoneal Cavity; Prostaglandins E; Protein Denaturation; Rats; Rats, Inbred Strains | 1987 |
Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.
Topics: Biological Products; Bone Resorption; Breast Neoplasms; Cells, Cultured; Cytokines; Dinoprostone; Estradiol; Female; Flufenamic Acid; Humans; Hypercalcemia; Indomethacin; Nafoxidine; Prostaglandins E; Pyrrolidines | 1985 |
An ex vivo method for evaluating prostaglandin synthetase activity in cortical slices of mouse brain.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cerebral Cortex; Dinoprostone; Escherichia coli; Flufenamic Acid; In Vitro Techniques; Indomethacin; Kinetics; Lipopolysaccharides; Male; Mice; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; Thromboxane B2 | 1985 |
Effects of prostaglandins on rat calvarial bone-cell calcium.
Topics: Alprostadil; Animals; Biological Transport, Active; Bone and Bones; Calcium; Cells, Cultured; Dinoprostone; Epoprostenol; Flufenamic Acid; Indomethacin; Osteoblasts; Osteoclasts; Parathyroid Hormone; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains | 1984 |
Bone resorptive factor produced by osteosarcoma cells with osteoblastic features is PGE2.
Topics: Animals; Bone Neoplasms; Bone Resorption; Cell Line; Chromatography, Thin Layer; Culture Media; Dinoprostone; Female; Flufenamic Acid; Indomethacin; Osteoblasts; Osteosarcoma; Pregnancy; Prostaglandins E; Rats | 1981 |
Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity.
Topics: Alprostadil; Animals; Anti-Inflammatory Agents; Aspirin; Body Fluids; Cathartics; Cricetinae; Diarrhea; Dinoprostone; Erythrocyte Membrane; Flufenamic Acid; Hemolysis; Indomethacin; Intestinal Mucosa; Intestines; Male; Meclofenamic Acid; Mefenamic Acid; Mesocricetus; Prostaglandin Antagonists; Prostaglandins E | 1982 |
Inhibition of eryptosis and intraerythrocytic growth of Plasmodium falciparum by flufenamic acid.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Anion Exchange Protein 1, Erythrocyte; Annexin A5; Anti-Inflammatory Agents; Calcium; Cell Death; Cell Size; Cell Survival; Chlorides; Dinoprostone; Dose-Response Relationship, Drug; Erythrocytes; Flow Cytometry; Flufenamic Acid; Gluconates; Humans; Parasitemia; Phosphatidylserines; Plasmodium falciparum; Potassium Chloride | 2007 |
Prostaglandin E2 induces chloride secretion through crosstalk between cAMP and calcium signaling in mouse inner medullary collecting duct cells.
Topics: Animals; Benzoates; Boron Compounds; Calcium; Calcium Signaling; Cell Line; Chloride Channels; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Dinoprostone; Egtazic Acid; Flufenamic Acid; Inositol 1,4,5-Trisphosphate Receptors; Ion Transport; Isoquinolines; Kidney Medulla; Kidney Tubules, Collecting; Mice; Patch-Clamp Techniques; Receptors, Prostaglandin E, EP4 Subtype; Sodium Channel Blockers; Sodium Channels; Sodium Chloride; Sulfonamides; Thiazolidines | 2014 |
Prostaglandin E2 differentially modulates the central control of eupnoea, sighs and gasping in mice.
Topics: Animals; Brain Stem; Cadmium; Calcium Channel Blockers; Dinoprostone; Female; Flufenamic Acid; Hypoxia; In Vitro Techniques; Male; Mice; Neurons; Respiration; Riluzole; Sodium Channel Blockers | 2015 |
cAMP/PKA Pathways and S56 Phosphorylation Are Involved in AA/PGE2-Induced Increases in rNaV1.4 Current.
Topics: Arachidonic Acid; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase Inhibitors; Dinoprostone; Flufenamic Acid; HEK293 Cells; Humans; Indomethacin; NAV1.4 Voltage-Gated Sodium Channel; Phosphorylation; Signal Transduction | 2015 |
Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid.
Topics: 20-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Dinoprostone; Female; Flufenamic Acid; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Silicon Dioxide; Sorafenib; Xenograft Model Antitumor Assays | 2020 |